The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).
Study Type
OBSERVATIONAL
Enrollment
1,000
Extract data from the digital medical records, the electroencephalographic and microbiologic database.
Cantonal Hospital Aarau (KSA)
Aarau, Switzerland
RECRUITINGClinic for Intensive Care Medicine, University Hospital Basel
Basel, Switzerland
RECRUITINGDemographics
age, sex
Time frame: between 01.01.2005 and 31.12.2023
Data from acute prehospital management by the emergency medical services (EMS)
extracted from the treatment protocols of the EMS
Time frame: between 01.01.2005 and 31.12.2023
Duration of ICU (intensive care unit) and hospital stay, and destination at discharge
Duration of ICU (intensive care unit) and hospital stay, and destination at discharge
Time frame: between 01.01.2005 and 31.12.2023
Date(s) of seizure(s) captured by electroencephalographic (EEG) data
Date(s) of seizure(s) captured by EEG
Time frame: between 01.01.2005 and 31.12.2023
Seizure history and etiology
withdrawal from anti seizure drugs, structural, infectious, or autoimmune causes
Time frame: between 01.01.2005 and 31.12.2023
Number and Duration of SE episodes
Number and Duration (time) of SE episodes
Time frame: between 01.01.2005 and 31.12.2023
Types of SE
Types of SE according to the current guidelines from the International League of Epilepsy (ILAE) (i.e., nonconvulsive with coma, SE with motor symptoms, focal nonconvulsive SE without coma, and subtle SE
Time frame: between 01.01.2005 and 31.12.2023
Additional features of the seizure
length, level of consciousness at onset, previous epileptic seizures
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: between 01.01.2005 and 31.12.2023
ICU Scoring Systems
Critical illness severity scores (e.g., acute physiology and chronic health Evaluation (APACHE II), simplified acute physiology score (SAPS II), sequential organ failure assessment (SOFA), etc.)
Time frame: between 01.01.2005 and 31.12.2023
Clinical neurologic monitoring scores
Clinical neurologic monitoring scores (e.g., Richmond Agitation-Sedation Scale (RASS) , Seda-tion-Agitation Scale (SAS), Glasgow Coma Score (GCS), Intensive Care Delirium Screening Checklist (ICDSC), Status Epilepticus Severity Score (STESS))
Time frame: between 01.01.2005 and 31.12.2023
Laboratory parameters
C-Reactive Protein (CRP), albumin, Lactate Dehydrogenase (LDH), Creatin-Kinase (CK), procalcitonin, white blood cell levels, creatinine, liver enzymes, blood gas analyses, metabolic data
Time frame: between 01.01.2005 and 31.12.2023
Outcome measure
in-hospital death, survival, survival with neurofunctional alteration, Glasgow Outcome Score, return to neurofunctional premorbid baseline, readmission
Time frame: between 01.01.2005 and 31.12.2023
Therapeutic features
duration, dosage and number of treatment medication, number of antiseizure drugs, invasive procedures, such as intubation, mechanical, ventilation, vasopressors, installation of central lines, nutrition
Time frame: between 01.01.2005 and 31.12.2023
Monitoring of vital signs
blood pressure, heart rate, respiratory rate, oxygen saturation of the blood, body temperature, level of consciousness
Time frame: between 01.01.2005 and 31.12.2023